1.原文連結：
https://reurl.cc/V6829R
2.原文內容：
A Chicago hospital treating severe Covid-19 patients with Gilead Sciences' ant
iviral medicine remdesivir in a closely watched clinical trial is seeing rapid
recoveries in fever and respiratory symptoms, with nearly all patients discha
rged in less than a week, STAT has learned.
一個芝加哥的醫院收療嚴重Covid病患的試驗，使用藥物後發燒及呼吸道症狀改善，幾乎
所有病人一週內出院。
The University of Chicago Medicine recruited 125 people with Covid-19 into Gil
ead's two Phase 3 clinical trials. Of those people, 113 had severe disease. Al
l the patients have been treated with daily infusions of remdesivir.
"The best news is that most of our patients have already been discharged, whic
h is great. We've only had two patients perish," said Kathleen Mullane, the Un
iversity of Chicago infectious disease specialist overseeing the remdesivir st
udies for the hospital.
125位病人中，113位為嚴重型患者。兩位死亡。
3.心得/評論：
原文其他內容是一些描述，例如此試驗非雙盲設計，無對照組。
四月底之前應該會有NEJM等級報告出來，到時候就可以知道細節。
不過就像教主說的，等知道細節都不知道噴到哪裡去了，美國防疫股盤後都大漲。